Archive for July 15, 2010

Streptococcus dysgalactiae subsp. equisimilis Bacteremia, Finland, 1995–2004

Emerging Infectious Diseases May 2010  V.16  N.5  p.843-846

Sari Rantala,  Susanna Vähäkuopus, Jaana Vuopio-Varkila, Risto Vuento, and Jaana Syrjänen

Tampere University Hospital, Tampere, Finland (S. Rantala, R. Vuento, J. Syrjänen); National Institute for Health and Welfare, Helsinki, Finland (S. Vähäkuopus, J. Vuopio-Varkila); and Medical School, University of Tampere, Tampere (J. Syrjänen)


We conducted a retrospective population-based study of 140 episodes of Streptococcus dysgalactiae subsp. equisimilis bacteremia occurring in Finland during 1995–2004. Rare emm types were associated with more severe disease and increased mortality rates. Skin and soft tissue infections were more frequent clinical signs among cases caused by common emm types.

Full Text  


July 15, 2010 at 5:44 pm Leave a comment

Possible Transmission of Pandemic (HIN1) 2009 Virus with Oseltamivir Resistance

Emerging Infectious Diseases May 2010  V.16  N.5  p.873


Michal Mandelboim,  Musa Hindiyeh, Tal Meningher, and Ella Mendelson

Chaim Sheba Medical Center, Ramat-Gan, Israel (M. Mandelboim, M. Hindiyeh, T. Meningher, E. Mendelson); Bar-Ilan University, Ramat-Gan (T. Meningher); and Tel-Aviv University, Ramat Aviv, Israel (E. Mendelson)

To the Editor: In March 2009, a new strain of influenza A (H1N1) virus of swine origin emerged; the virus had crossed the species barrier to humans and acquired the capability of human-to-human transmission. Soon after, the World Health Organization raised the worldwide pandemic alert to level 6 (, declaring the first influenza pandemic in the past 42 years. The virus was named influenza A pandemic (H1N1) 2009 virus. The illness caused by this virus is particularly dangerous for pregnant women and for patients with chronic diseases (1). The preferred treatment is a neuraminidase inhibitor, zanamivir or oseltamivir

Full Text  


July 15, 2010 at 5:43 pm Leave a comment

Transmission of Hemagglutinin D222G Mutant Strain of Pandemic (H1N1) 2009 Virus

Emerging Infectious Diseases May 2010  V.16  N.5  p.863-865

Simona Puzelli,  Marzia Facchini, Domenico Spagnolo, Maria A. De Marco, Laura Calzoletti, Alessandro Zanetti, Roberto Fumagalli, Maria L. Tanzi, Antonio Cassone, Giovanni Rezza, Isabella Donatelli, and the Surveillance Group for Pandemic A (H1N1) 2009 Influenza Virus in Italy1

National Institute of Health, Rome, Italy (S. Puzelli, M. Facchini, D. Spagnolo, M.A. De Marco, L. Calzoletti, A. Cassone, G. Rezza, I. Donatelli); Università degli Studi di Milano, Milan, Italy (A. Zanetti); Università degli Studi di Milano-Bicocca, Milan (R. Fumagalli); and Università degli Studi di Parma, Parma, Italy (M.L. Tanzi)


A pandemic (H1N1) 2009 virus strain carrying the D222G mutation was identified in a severely ill man and was transmitted to a household contact. Only mild illness developed in the contact, despite his obesity and diabetes. The isolated virus reacted fully with an antiserum against the pandemic vaccine strain.

Full Text  


July 15, 2010 at 5:41 pm Leave a comment


July 2010

Posts by Month

Posts by Category